Fifty four patients with cystic fibrosis, aged 3-67 years, were studied prospectively for pulmonary mycobacterial infection. Sputum smears and cultures were carried out and intradermal skin tests performed. The following antigens were used for intradermal injections: PPD-T (PPD tuberculin in Tween diluent, 2 TU/0-1 ml), PPD-A (M avium antigen RS 10, 01 HIg/ 0-1 ml), PPD-I (M intracellulare antigen RS 0-1 pg/0 1 ml), PPD-S (M scrofulaceum antigen RS 95, 0-1 ug/0-1 ml), PPD-K (M kansasii, RS 30, 0-1 ug/0 1 ml). All antigens were obtained from Statens Seruminstitut, tuberculin department, DK-2300 Copenhagen S, Denmark. Each antigen (0-1 ml) was injected on the volar side of the middle third of the forearm and read at 72 hours by two specially trained nurses. A palpable induration of more than 6 mm diameter was regarded as positive.
Abstract
Fifty four patients with cystic fibrosis, aged 3-67 years, were studied prospectively for pulmonary mycobacterial infection. Sputum smears and cultures were carried out and intradermal skin tests performed. Mycobacteria were cultured from six patients in association with clinical deterioration; four patients had positive direct smears.
Mycobacterium tuberculosis, M aviumintracellulare, M At least three direct smear examinations and three cultures for mycobacteria were performed for each patient except for eight patients not producing sputum. Gastric lavage was performed in six patients, five of whom had one or more strongly positive skin test responses. Smears were examined after being stained with auramine. Mycobacterial isolates were identified by standard biochemical methods.5 Susceptibility to streptomycin, amikacin, isoniazid, ethambutol and rifampicin was determined on Lowenstein-Jensen medium by the resistance ratio method.6
Routine laboratory haematological determinations, serum immunoglobulin measurements, and liver and renal function tests were performed. Spirometric values were compared with those of healthy children and adults.78 STATISTICS Statistical analyses were performed by means of the X2 test. The results of skin tests in the other patients with cystic fibrosis are given in table 2. One third of the patients had a positive response to PPD tuberculin and almost half to one or more antigens from non-tuberculous mycobacteria. Fifteen of the 21 patients who had a positive response to one or more non-tuberculous antigens had a positive response to PPD tuberculin. Only two patients had a positive response to PPD tuberculin and a negative response to all other antigens; one had had BCG vaccination 18 months before. Of those with a positive response to any non-tuberculous antigen, 13 had a positive response to three of the four antigens, seven to two, and two to one. Results Only one of 11 patients under the age of 11 had a positive response to any antigen (PPD tuberculin in the one case) despite prior BCG vaccination. Sensitisation to antigens increased with age (table 2) .
Positive skin test responses to PPD-tuberculin occurred in 2000 of patients aged [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] years with negative sputum cultures, compared with 4400 of healthy 14 year old Swedish children who had BCG vaccination at birth9 (p < 0 05) and half of 8-9 year old Swedish children vaccinated with BCG (p < 005).'°N o patient reacted to any of the non-tuberculous antigens before the age of 1 1, compared with 62-68°ofhealthy vaccinated 8-9 year old children'0 (p < 0-001). A difference in the opposite direction was noticed when indurations of more than 10 mm were compared; these occurred in 3800 (M aviumintracellulare) and 3100 (M scrofulaceum) of patients with cystic fibrosis (data not shown) and in 1000 and 130o of healthy children'0 (p < 0-001 and p < 0-001 respectively).
No relation was found between -skin test results and erythrocyte sedimentation rate, total white blood cell count, differential white cell count, serum IgG, clinical state, FEVy, or chest radiographs (data not shown). Only two of the patients with positive mycobacterial cultures were in a poor nutritional state (<2 SD for weight), and one was receiving corticosteroid treatment; none had diabetes mellitus. The relevance of mycobacteria isolated from sputum may be difficult to assess, especially in patients with cystic fibrosis or other chronic pulmonary diseases. We found both an obligate pathogen (M tuberculosis) and one isolate (M gordonae) that is rarely associated with disease.3 14 M avium-intracellulare and M kansasii form an intermediate group, causing either progressive lung disease or colonisation only. '5 The deterioration in lung function observed in all patients at the time of positive sputum culture suggests that these mycobacteria were causing disease (figure). Furthermore, infection is more probable than colonisation in cases with positive direct smears because these indicate a large number of mycobacteria in the sputum. Such findings with repeated isolation of the same bacterial strain and skin reactivity to the relevant antigen may be helpful for diagnosis.'6'7 As mycobacteria are known to possess cross reacting antigens, various PPD preparations should be used for comparison and chosen according to geographical distribution.'8 Our patients seemed to be less sensitised to non-tuberculous antigens than healthy young people in Sweden, but when positive the reaction seemed to be stronger than that in the healthy population. Our finding of a lower rate of sensitisation in patients with cystic fibrosis than in healthy children seems to be age related and might be related to biochemical changes during the progression-of the disease. One progressive disturbance in cystic fibrosis is deficiency of essential fatty acids'9 and abnormal eicosanoid production (Strandvik et al, unpublished observations). Interestingly, administration of indomethacin, in vitro and in vivo, reverses subnormal immune reactivity to non-tuberculin mycobacterial antigens,20 because patients with cystic fibrosis overproduce some eicosanoids.2' T cell function has been considered to be normal in patients with cystic fibrosis,22 but further studies are needed.
Discussion
Our study indicates that mycobacterial infection should be considered in patients with cystic fibrosis who deteriorate without known cause. Sputum examination must be performed because skin tests are of limited value. In contrast to some earlier reports, none of our cases was fatal, indicating that chemotherapy may be life saving in non-tuberculous mycobacterial infection.
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